- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02414789
Lyme Borreliosis and Early Cutaneous Diagnostic (DIABOLYC)
Test and evaluate a new diagnostic method (SRM-MS/MS: Selected Reaction Monitoring- Mass spectrometry) for Lyme Borreliosis on human skin biopsies. Patients included are those with the early skin manifestation (erythema migrans).
This new proteomic method will be compared to the two existing method: culture of Borrelia and PCR detection of Borrelia (DNA detection of the bacteria).
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Besancon, France
- Centre Hospitalo-Universitaire Jean Minjoz
-
Chalon-sur-Saône, France
- Centre Hospitalier William Morey
-
Colmar, France
- Hopital Pasteur
-
Mulhouse, France
- Hôpital E. Muller
-
Reims, France
- Hôpital Robert Debré
-
Strasbourg, France, 67091
- Hôpitaux Universitaires de Strasbourg
-
Thionville, France
- Hôpital Bel Air
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Erythema migrant as criteria EUCALB or atypical form associated to tick's sting
- Patient having signed a consent
- Patient affiliated to a social security scheme
Exclusion Criteria:
- Prior treatment with antibiotics
- Erythema migrans on the face
- Bleeding disorders
- Anticoagulant treatment
- Inability to give clear information (subject in an emergency situation, understanding of the topic difficulty, ...)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SRM / MS-MS
|
Skin biopsies of patients with Lyme disease (erythema migrans) infected with Borrelia burgdorferi sensu lato will be analyzed by three diagnostic techniques : molecular technique (PCR), biological technique (culture of the bacteria) and proteomics technique (SRM/ MS-MS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare the sensitivity (percentage of positive tests) of the SRM / MS-MS to techniques of PCR and culture Borrelia
Time Frame: One year study
|
percentage of positive tests with all three techniques (SRM/MS-MS ; PCR ; culture)
|
One year study
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Skin Diseases
- Infections
- Stomatognathic Diseases
- Mouth Diseases
- Vector Borne Diseases
- Gram-Negative Bacterial Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Skin Diseases, Infectious
- Skin Manifestations
- Skin Diseases, Bacterial
- Tick-Borne Diseases
- Borrelia Infections
- Spirochaetales Infections
- Tongue Diseases
- Glossitis
- Erythema
- Lyme Disease
- Erythema Chronicum Migrans
- Glossitis, Benign Migratory
Other Study ID Numbers
- 6084
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Erythema Migrans
-
National Institute of Allergy and Infectious Diseases...Completed
-
University Medical Centre LjubljanaUnknown
-
Quidel CorporationCompletedBorrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)United States
-
University Medical Centre LjubljanaCompleted
-
University Medical Centre LjubljanaRecruiting
-
University Medical Centre LjubljanaUniversity of Ljubljana School of Medicine, SloveniaCompleted
-
University Medical Centre LjubljanaMedical University of Vienna; Harvard University; University of Ljubljana School...Unknown
-
University Medical Centre LjubljanaCompleted
-
University Medical Centre LjubljanaUniversity of Ljubljana School of Medicine, SloveniaCompleted
-
University Medical Centre LjubljanaUniversity of Ljubljana School of Medicine, SloveniaRecruiting
Clinical Trials on Skin biopsies
-
Assistance Publique - Hôpitaux de ParisCompletedIntestinal Epithelial Dysplasia | Tufting EnteropathyFrance
-
Nantes University HospitalTerminatedInherited Arrhythmias and ValvulopathiesFrance
-
Medical University of ViennaRecruiting
-
Association pour la Recherche Clinique et ImmunologiqueNot yet recruitingHidradenitis Suppurativa (HS)France
-
Institut de Cancérologie de LorraineCompletedFibrosis | Breast CarcinomaFrance
-
Hospital of South West JutlandOdense University HospitalRecruitingRheumatoid Arthritis | Widespread Chronic Pain | Fibromyalgia, Secondary | Muscle DisorderDenmark
-
University Hospital, LilleGlaxoSmithKlineUnknownSystemic Sclerosis | Systemic SclerodermaFrance
-
Poitiers University HospitalRecruitingImmune Response | Staphylococcus Aureus | Atopic Dermatitis | Cytokines | Bacterial Toxins | T Cells SubsetsFrance
-
Hospices Civils de LyonNot yet recruitingLowry Wood Syndrome | Roifman Syndrome | Taybi Linder Syndrome | Microcephalic Osteodysplastic Primordial Dwarfism Types I and IIIFrance
-
Henry Ford Health SystemM.D. Anderson Cancer CenterCompleted